Bavarian Cancer Registry, Bavarian Health and Food Safety Authority
Nuremberg, Bavaria, 90441, Germany
Location status: Recruiting
NCT Number: NCT06282016
Recent studies show an increase in neuroendocrine neoplasms, especially for the digestive tract. Previous studies suggest various risk factors that were observed for various tumor sites, e.g. a family history of cancer, tobacco and alcohol consumption as well as metabolic disorders including diabetes and obesity. A risk factor that has been little studied to date is depressive disorders, which could increase the risk of neuroendocrine neoplasms either independently or through associated risk behaviors and/or antidepressant medication. The aim of this study is to identify risk factors for neuroendocrine neoplasms based on a case-control study in order to better understand the increase of neuroendocrine neoplasms in recent decades. The study is based on a record linkage of data from the Bavarian Cancer Registry and data from the Bavarian Association of Statutory Health Insurance Accredited Physicians. While the data from the Bavarian Cancer Registry enables the identification of neuroendocrine neoplasms on the basis of histopathological findings and thus is the basis for selecting cases, the claims data from the Bavarian Association of Statutory Health Insurance Accredited Physicians provides the source population as well data on diagnoses and thus enables the investigation of risk factors.
Interested in participating?
Request InfoAll sexes
Observational
Nuremberg, Bavaria, 90441, Germany
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observation of risk factors in cases and controls
Time frame: 2021-2023
Neuroendocrine neoplasm of the bronchopulmonary system
Time frame: 2021-2023
Neuroendocrine neoplasm of the gastroenteropancreatic system
Time frame: 2021-2023
Neuroendocrine tumour of the bronchopulmonary system
Time frame: 2021-2023
Neuroendocrine carcinoma of the bronchopulmonary system
Time frame: 2021-2023
Neuroendocrine tumour of the gastroenteropancreatic system
Time frame: 2021-2023
Neuroendocrine carcinoma of the gastroenteropancreatic system
Contact information is provided by the study sponsor or research team.
Jacqueline Müller-Nordhorn
CONTACT
+49-(0)9131-6808 ext. 4331
Sven Voigtländer
CONTACT
+49-(0)9131-6808 ext. 2927
Bavarian Cancer Registry
Other Gov
Risk Factors for Neuroendocrine Neoplasms: a Case-control Study Based on a Record Linkage of Registry and Claims Data
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06523582
Abnormalities, Multiple, Adenocarcinoma
Mexico City, Mexico
View Trial DetailsNCT03095274
Neoplasms, Neoplasms by Histologic Type
Badalona, Barcelona, Spain
View Trial DetailsNCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06252649
Colonic Diseases, Colorectal Neoplasms
Chandler, Arizona, United States
View Trial Details